Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation

Gerald V. Naccarelli, Frank Peacock

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with an increased risk of cardiovascular morbidity and mortality, especially due to ischemic stroke. The occurrence of AF leads to atrial electrical and structural remodeling. The renin-angiotensin system appears to play a role in the development of atrial arrhythmias by its involvement in both of these processes. Large-scale hypertension trials and heart failure trials have indicated the potential value of angiotensin II receptor blockers in the treatment of AF.

Original languageEnglish (US)
Pages (from-to)783-791
Number of pages9
JournalVascular Health and Risk Management
Volume5
StatePublished - Dec 1 2009

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Hematology
  • Public Health, Environmental and Occupational Health
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation'. Together they form a unique fingerprint.

Cite this